Stanford V
Term · Oncology and biomedicine · MLC-T-ONC-008277
An abbreviation for a chemotherapy combination that is used to treat Hodgkin lymphoma and is being studied in the treatment of other types of cancer. It includes the drugs mechlorethamine, doxorubicin hydrochloride, vinblastine sulfate, vincristine sulfate, bleomycin sulfate, etoposide phosphate, and prednisone and was developed at Stanford University. Also called Stanford V regimen.
| Identifier | MLC-T-ONC-008277 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Stanford V regimen |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008277",
"term": "Stanford V",
"field": "Oncology and biomedicine",
"definition": "An abbreviation for a chemotherapy combination that is used to treat Hodgkin lymphoma and is being studied in the treatment of other types of cancer. It includes the drugs mechlorethamine, doxorubicin hydrochloride, vinblastine sulfate, vincristine sulfate, bleomycin sulfate, etoposide phosphate, and prednisone and was developed at Stanford University. Also called Stanford V regimen.",
"synonyms": [
"Stanford V regimen"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/stanford-v/"
}
Record 15,624 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.